Cargando…
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175044/ https://www.ncbi.nlm.nih.gov/pubmed/34090624 http://dx.doi.org/10.1016/S0140-6736(21)01290-3 |
| _version_ | 1783702977571192832 |
|---|---|
| author | Wall, Emma C Wu, Mary Harvey, Ruth Kelly, Gavin Warchal, Scott Sawyer, Chelsea Daniels, Rodney Hobson, Philip Hatipoglu, Emine Ngai, Yenting Hussain, Saira Nicod, Jerome Goldstone, Robert Ambrose, Karen Hindmarsh, Steve Beale, Rupert Riddell, Andrew Gamblin, Steve Howell, Michael Kassiotis, George Libri, Vincenzo Williams, Bryan Swanton, Charles Gandhi, Sonia Bauer, David LV |
| author_facet | Wall, Emma C Wu, Mary Harvey, Ruth Kelly, Gavin Warchal, Scott Sawyer, Chelsea Daniels, Rodney Hobson, Philip Hatipoglu, Emine Ngai, Yenting Hussain, Saira Nicod, Jerome Goldstone, Robert Ambrose, Karen Hindmarsh, Steve Beale, Rupert Riddell, Andrew Gamblin, Steve Howell, Michael Kassiotis, George Libri, Vincenzo Williams, Bryan Swanton, Charles Gandhi, Sonia Bauer, David LV |
| author_sort | Wall, Emma C |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8175044 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81750442021-06-04 Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination Wall, Emma C Wu, Mary Harvey, Ruth Kelly, Gavin Warchal, Scott Sawyer, Chelsea Daniels, Rodney Hobson, Philip Hatipoglu, Emine Ngai, Yenting Hussain, Saira Nicod, Jerome Goldstone, Robert Ambrose, Karen Hindmarsh, Steve Beale, Rupert Riddell, Andrew Gamblin, Steve Howell, Michael Kassiotis, George Libri, Vincenzo Williams, Bryan Swanton, Charles Gandhi, Sonia Bauer, David LV Lancet Correspondence Elsevier Ltd. 2021 2021-06-03 /pmc/articles/PMC8175044/ /pubmed/34090624 http://dx.doi.org/10.1016/S0140-6736(21)01290-3 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Wall, Emma C Wu, Mary Harvey, Ruth Kelly, Gavin Warchal, Scott Sawyer, Chelsea Daniels, Rodney Hobson, Philip Hatipoglu, Emine Ngai, Yenting Hussain, Saira Nicod, Jerome Goldstone, Robert Ambrose, Karen Hindmarsh, Steve Beale, Rupert Riddell, Andrew Gamblin, Steve Howell, Michael Kassiotis, George Libri, Vincenzo Williams, Bryan Swanton, Charles Gandhi, Sonia Bauer, David LV Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination |
| title | Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination |
| title_full | Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination |
| title_fullStr | Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination |
| title_full_unstemmed | Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination |
| title_short | Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination |
| title_sort | neutralising antibody activity against sars-cov-2 vocs b.1.617.2 and b.1.351 by bnt162b2 vaccination |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175044/ https://www.ncbi.nlm.nih.gov/pubmed/34090624 http://dx.doi.org/10.1016/S0140-6736(21)01290-3 |
| work_keys_str_mv | AT wallemmac neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT wumary neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT harveyruth neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT kellygavin neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT warchalscott neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT sawyerchelsea neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT danielsrodney neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT hobsonphilip neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT hatipogluemine neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT ngaiyenting neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT hussainsaira neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT nicodjerome neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT goldstonerobert neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT ambrosekaren neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT hindmarshsteve neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT bealerupert neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT riddellandrew neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT gamblinsteve neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT howellmichael neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT kassiotisgeorge neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT librivincenzo neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT williamsbryan neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT swantoncharles neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT gandhisonia neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination AT bauerdavidlv neutralisingantibodyactivityagainstsarscov2vocsb16172andb1351bybnt162b2vaccination |